Correlation Between BriaCell Therapeutics and Entera Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and Entera Bio, you can compare the effects of market volatilities on BriaCell Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Entera Bio.

Diversification Opportunities for BriaCell Therapeutics and Entera Bio

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between BriaCell and Entera is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Entera Bio go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and Entera Bio

Given the investment horizon of 90 days BriaCell Therapeutics Corp is expected to under-perform the Entera Bio. In addition to that, BriaCell Therapeutics is 1.3 times more volatile than Entera Bio. It trades about -0.12 of its total potential returns per unit of risk. Entera Bio is currently generating about -0.15 per unit of volatility. If you would invest  140.00  in Entera Bio on June 26, 2022 and sell it today you would lose (21.00)  from holding Entera Bio or give up 15.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BriaCell Therapeutics Corp  vs.  Entera Bio

 Performance (%) 
       Timeline  
BriaCell Therapeutics 
BriaCell Performance
0 of 100
Over the last 90 days BriaCell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BriaCell Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

BriaCell Price Channel

Entera Bio 
Entera Performance
0 of 100
Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Entera Price Channel

BriaCell Therapeutics and Entera Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BriaCell Therapeutics and Entera Bio

The main advantage of trading using opposite BriaCell Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.
BriaCell Therapeutics vs. Saputo Inc
BriaCell Therapeutics vs. Jde Peets NV
BriaCell Therapeutics vs. Kellogg Company
BriaCell Therapeutics vs. Kikkoman Corp
The idea behind BriaCell Therapeutics Corp and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Entera Bio vs. Campbell Soup
Entera Bio vs. Kellogg Company
Entera Bio vs. JM Smucker
Entera Bio vs. Grupo Bimbo SA
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go